What Are Peptides and Why Are Practitioners Paying Attention?
Peptides are short chains of amino acids that act as signaling molecules throughout the body — influencing growth hormone release, immune function, tissue repair, inflammation, and cognitive performance. Over the past decade, peptide therapies have moved from research settings into clinical practice, with a growing number of practitioners integrating them into optimization protocols.
The Regulatory Landscape
The peptide landscape is complex from a regulatory standpoint. Some peptides are FDA-approved medications (e.g., semaglutide for diabetes/obesity). Others exist in a gray area — available through 503A compounding pharmacies for individualized patient prescriptions but not FDA-approved for specific indications. Practitioners must stay current with FDA guidance on compounded peptides, as the regulatory environment has shifted.
Growth Hormone Secretagogues
Growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormone analogs (GHRHs) stimulate the pituitary to release growth hormone naturally. Common combinations include CJC-1295 with Ipamorelin, and Sermorelin. These are used for anti-aging, body composition, sleep quality, and recovery. They stimulate pulsatile GH release — more physiologic than exogenous HGH.
BPC-157 for Tissue Repair
Body Protection Compound-157 (BPC-157) is a synthetic peptide derived from a protein found in gastric juice. It has demonstrated remarkable tissue-healing properties in preclinical studies — accelerating healing in tendons, ligaments, muscle, and gut tissue. Athletes and active patients use it for injury recovery. Administration is typically subcutaneous injection or oral capsule (though oral bioavailability is debated).
Thymosin Beta-4 and TB-500
Thymosin Beta-4 (TB-500) promotes angiogenesis, tissue repair, and anti-inflammation. It’s particularly valued in orthopedic recovery protocols. TB-500 is a fragment of thymosin beta-4 with similar mechanisms and is commonly used in clinical peptide protocols for joint and soft tissue injuries.
GLP-1 Agonists: The Practitioner’s Weight Loss Tool
Semaglutide and tirzepatide have transformed weight management medicine. As a practitioner, understanding GLP-1 agonist mechanisms, appropriate patient selection, dosing protocols, nutritional adjuncts, and long-term management is now a core competency in metabolic medicine. These medications require careful monitoring and patient education to maximize outcomes.
Clinical Considerations and Informed Consent
Be transparent with patients about what is and isn’t FDA-approved. Obtain thorough informed consent that addresses the investigational nature of some peptides, known side effects, and the importance of sourcing from licensed compounding pharmacies. Documentation is everything in this space.